Lataa...
The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection
Acetylsalicylic acid (aspirin) is commonly used for primary and secondary prevention of cardiovascular diseases. Aspirin use is associated with better outcomes among COVID‐19 positive patients. We hypothesized that the aspirin use for primary cardiovascular disease prevention might have a protective...
Tallennettuna:
| Julkaisussa: | FEBS J |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013755/ https://ncbi.nlm.nih.gov/pubmed/33621437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15784 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|